A non-randomized comparative clinical trial on the add-on effect of yoni kshalanam and yoni pichu in congestive dysmenorrhea.
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 入组人数
- 30
- 试验地点
- 1
研究概览
简要总结
Dysmenorrhea is a common gynecological condition affecting women of reproductive age. Secondary dysmenorrhea or congestive dysmenorrhea is characterized by deep pelvic pain beginning before menstruation and is often associated with underlying pelvic pathology. In Ayurveda this condition can be correlated with Vatiki Yonivyapad caused by vitiation of Apana Vata. Recent evidence suggests a relationship between vaginal imbalance and menstrual pain, supporting the role of local vaginal therapies. This non randomized comparative clinical trial aims to evaluate the add on effect of Yoni Kshalanam and Yoni Pichu in congestive dysmenorrhea. The study will be conducted at the Department of Streeroga and Prasutitantra Government Ayurveda College Hospital for Women and Children Poojappura. Women aged twenty to forty five years diagnosed with congestive dysmenorrhea will be divided into two groups. The trial group will receive oral Saptasaram Kashaya along with Yoni Kshalanam and Yoni Pichu while the control group will receive oral Saptasaram Kashaya alone. Pain will be assessed using standard clinical assessment methods and the data will be statistically analyzed.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 盲法
- None
入排标准
- 年龄范围
- 20.00 Year(s) 至 45.00 Year(s)（—）
- 性别
- Female
入选标准
- •Women aged 20 to 45 years with regular menstrual cycles (28 ± 7 days), diagnosed with congestive dysmenorrhea, and willing to participate in the study will be included.
- •Participants should have a clinical and/or ultrasonographic diagnosis of congestive dysmenorrhea associated with one or more underlying pelvic pathologies, namely endometriosis, adenomyosis, uterine fibroids, chronic pelvic inflammatory disease, acquired retroversion of the uterus, or endometrial polyp.
- •Only those fulfilling the above criteria will be enrolled in the study.
排除标准
- •Women with endometriotic cysts larger than five centimetres, malignancy, intrauterine contraceptive device in situ, elevated serum CA 125 levels above thirty five units per millilitre, pregnancy or lactation, or uncontrolled systemic illness will be excluded.
研究者
Nandu Thankappan
Government Ayurveda Medical College and Hospital, Thiruvananthapuram